CYTEK BIOSCIENCES, INC. (CTKB) Operating income 2020–2025
CYTEK BIOSCIENCES, INC. (CTKB) annual operating income history from SEC filings — each fiscal year as reported.
-$40.4MFY2025 · since FY2020: $13.7M → -$40.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$40.4M | -96.8% |
| FY2024 | -$20.5M | +26.3% |
| FY2023 | -$27.8M | -1443.5% |
| FY2022 | -$1.8M | -119.7% |
| FY2021 | $9.2M | -33.0% |
| FY2020 | $13.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CTKB financial trends
CTKB RevenueCTKB Net incomeCTKB Net marginCTKB Gross profitCTKB Gross marginCTKB Operating marginCTKB Operating cash flowCTKB Free cash flowCTKB Capital expendituresCTKB Return on equityCTKB Stock buybacksCTKB Dividends paidCTKB Total assetsCTKB Total liabilitiesCTKB Shareholders’ equityCTKB overview →